Advances in basic and clinical immunology in 2006

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 2, 2007, Pages 263-270

  Chinen, Javier ^a   Shearer, William T ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

angioedema; CD1d T cells; drug allergy; Immunology; immunomodulators; primary immunodeficiencies; Toll like receptors; vaccines

Indexed keywords

AMOXICILLIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIBIOTIC AGENT; ANTIBODY; ANTIFUNGAL AGENT; CARBAMAZEPINE; CYTOKINE; DNA VACCINE; ETANERCEPT; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; INTERLEUKIN 15; LEUKOTRIENE; LIVE VACCINE; PHENYTOIN; PROSTAGLANDIN; RESIQUIMOD; SMALLPOX VACCINE; STEROID; SULFAMETHOXAZOLE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VACCINE; VANCOMYCIN;

ADOPTIVE TRANSFER; ALLERGIC REACTION; ALLERGIC RHINITIS; ANGIONEUROTIC EDEMA; ASTHMA; CLINICAL IMMUNOLOGY; COMMON VARIABLE IMMUNODEFICIENCY; DNA SEQUENCE; DRUG HYPERSENSITIVITY; GRANULOMATOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOTHERAPY; INFECTION; INFECTION CONTROL; INNATE IMMUNITY; MEDICAL RESEARCH; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SMALLPOX; TULAREMIA; VACCINATION;

ALLERGENS; ALLERGY AND IMMUNOLOGY; ANGIONEUROTIC EDEMA; ANTIBODY FORMATION; ANTIGENS, CD1; CD4-POSITIVE T-LYMPHOCYTES; COMPLEMENT C1 INHIBITOR PROTEIN; DRUG HYPERSENSITIVITY; HIV INFECTIONS; HUMANS; HYPERSENSITIVITY; IMMUNITY; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOTHERAPY; INFECTION; INFECTION CONTROL; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TOLL-LIKE RECEPTORS; VACCINES;

EID: 34547100773     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.05.031     Document Type: Review

References (65)

1. Kaisho T., and Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol 117 (2006) 979-987
2. Schaub B., Lauener R., and von Mutius E. The many faces of the hygiene hypothesis. J Allergy Clin Immunol 117 (2006) 969-977
3. Liu A.H., and Leung D.Y.M. Renaissance of the hygiene hypothesis. J Allergy Clin Immunol 117 (2006) 1063-1069
4. Horner A.A. Toll-like receptor ligands and atopy: a coin with at least two sides. J Allergy Clin Immunol 117 (2006) 1133-1140
5. Taylor R.C., Richmond P., and Upham J.W. Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen. J Allergy Clin Immunol 117 (2006) 1148-1154
6. Hoarau C., Lagaraine C., Martin L., Velge-Roussel F., and Lebranchu Y. Supernatant of Bifidobacterium breve induces dencritic cell maturation, activation and survival through a Toll-like receptor 2 pathway. J Allergy Clin Immunol 117 (2006) 696-702
7. Fili L., Ferri S., Guarna F., Sampognaro S., Manuelli C., Liotta F., et al. Redirection of allergen-specific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL12/IFN release. J Allergy Clin Immunol 118 (2006) 511-518
8. Thivierge M., Stankova J., and Rola Plaesczynski M. Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells. J Allergy Clin Immunol 117 (2006) 1155-1162
9. McDonald D.R., Brown D., Bonilla F.A., and Geha R.S. Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor-dependent innate antiviral immune responses. J Allergy Clin Immunol 118 (2006) 1357-1362
10. Sudowe S., Portugal I.L., Montermann E., Ross R., and Reske-Kunz A.B. Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells. J Allergy Clin Immunol 117 (2006) 196-203
11. Gablez M., Schelblhofer S., Kern K., Leitner W.W., Stoecklinger A., Hauser-Kronberger C., et al. Immunization with a low-dose replicon DNA vaccine encoding Phl p5 effectively prevents allergic sensitization. J Allergy Clin Immunol 118 (2006) 734-741
12. Bauer R., Scheliblhofer S., Kern K., Gruber C., Stepanoska T., Thalhamer T., et al. Generation of hypoallergenic DNA vaccines by forced ubiquitination: preventive and therapeutic effects in a mouse model of allergy. J Allergy Clin Immunol 118 (2006) 269-276
13. Higgins D., Rodriguez R., Milley R., Marshall J., Abbate C., dela Cruz T., et al. Modulation of immunogenicity and allergenicity by controlling the number of immunostimulatory oligonucleotides linked to Amb a 1. J Allergy Clin Immunol 118 (2006) 504-510
14. Kundig T.M., Santi G., Schnetzler G., Wolf C., Vavricka B.M.P., Fulurija A., et al. Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. J Allergy Clin Immunol 117 (2006) 1470-1476
15. Seidel-Guyenot W., Perschon S., Dechant N., Alt R., Knop J., and Steinbrick K. Low zone tolerance induced by systemic application of allergens inhibits Tc1-mediated skin inflammation. J Allergy Clin Immunol 117 (2006) 1170-1177
16. Russano A.M., Agea E., Corazzi L., Postle A.D., De Libero G., Porcelli S., et al. Recognition of pollen-derived phosphatidyl-ethanolamine by human CD1d restricted gd T cells. J Allergy Clin Immunol 117 (2006) 1178-1184
17. Elkhal A., Pichavant M., He R., Scott J., Meyer E., Goya S., et al. CD1d restricted natural killer T cells are not required for allergic skin inflammation. J Allergy Clin Immunol 118 (2006) 1363-1368
18. Pham-Thi N., deBlic J., LeBourgeois M., Dy M., Scheinmann P., and Leite-de-Moraes M.C. Enhanced frequency of immunoregulatory invariant natural killer T cells in the airways of children with asthma. J Allergy Clin Immunol 117 (2006) 217-218
19. KleinJan A., Wilart M., van Rijt L., Braunstahl G.J., Leman K., Jung S., et al. An essential role for dendritic cells in human and experimental allergic rhinitis. J Allergy Clin Immunol 118 (2006) 1117-1125
20. Polte T., Behrendt A.K., and Hansen G. Direct evidence for a critical role of CD30 in the development of allergic asthma. J Allergy Clin Immunol 118 (2006) 942-948
21. Aoi N., Masuda T., Murakami D., Yajima T., Mizubuchi H., Yamada H., et al. IL-15 prevents allergic rhinitis through reactivation of antigen-specific CD8+ cells. J Allergy Clin Immunol 117 (2006) 1359-1366
22. Yakindag A., He R., Laouini D., Alerius M., Carroll M., Oettgen H.C., et al. The complement component C3 plays a critical role in both TH1 and TH2 responses to antigen. J Allergy Clin Immunol 117 (2006) 1455-1461
23. Grinnan D., Sung S.S., Dougherty J.A., Knowles A.R., Allen M.B., Rose C.E., et al. Enhanced allergen-induced airway inflammation in paucity of lymph node T cell (plt) mutant mice. J Allergy Clin Immunol 118 (2006) 1234-1241
24. Lamoreaux J., Stankova J., and Roda-Plesaczynski. Leukotriene D4 enhances immunoglobulin production in CD40-activated human B lymphocytes. J Allergy Clin Immunol 117 (2006) 924-930
25. Trudeau J., Hu H., Chibana K., Chu H.W., Westcott J.Y., and Wenzel S.E. Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13. J Allergy Clin Immunol 117 (2006) 1446-1454
26. Gold D.R., Willworth B.M., Tantisira K.G., Finn P.W., Schaub B., Perkins D.L., et al. Associations of cord blood fatty acids with lymphocyte proliferation, IL-13, and IFN-g. J Allergy Clin Immunol 117 (2006) 931-938
27. Liu S.M., Xavier R., Good K.L., Chtanova T., Newton R., Sisavanh M., et al. Immune cell transcriptome datasets reveal novel leukocyte subset-specific genes and genes associated with allergic processes. J Allergy Clin Immunol 118 (2006) 496-503
28. Kamchaisatian W., Wanwatsuntikul W., Sleasman J.W., and Tangalnmankong N. Validation of current joint American Academy of Allergy, Asthma and Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children. J Allergy Clin Immunol 118 (2006) 1336-1341
29. Uekert S.J., Akan G., Evans M.D., Li Z., Roberg K., Tisler C., et al. Sex-related differences in immune development and the expression of atopy in early childhood. J Allergy Clin Immunol 118 (2006) 1375-1381
30. Allakhverdi Z., Fitzpatrick D., Bolsvert A., Baba N., Boughermouh S., Sarfati M., et al. Expression of CD103 identifies human regulatory T-cell subsets. J Allergy Clin Immunol 118 (2006) 1342-1349
31. Nahm D.H., Lee K.H., Shin J.Y., Ye Y.M., Kang Y., and Park H.S. Identification of a-enolase as an autoantigen associated with severe asthma. J Allergy Clin Immunol 118 (2006) 376-381
32. *0101 tetramer-binding CD4+ T cells. J Allergy Clin Immunol 118 (2006) 1350-1356
33. Ballow M. Biologic immune modifiers: trials and tribulations: are we there yet?. J Allergy Clin Immunol 118 (2006) 1209-1215
34. Notarangelo L., Casanova J.L., Conley M.E., Chapel H., Fischer A., Puck J., et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol 117 (2006) 883-896
35. Garcia-Laorden M.I., Garcia-Saavedra A., RodriguezdeCastro F., Violan J., Rojas O., and Blanquer J. Low clinical penetrance of mannose-binding lectin-associated serine protease 2 deficiency. J Allergy Clin Immunol 118 (2006) 1384-1387
36. Castigli E., and Geha R.S. Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol 117 (2006) 740-746
37. Berglund L.J., Jones G.J., Murali R., and Fulcher D.A. TACI mutation with invasive CD8 T-cell lymphoproliferation in a patient with common variable immunodeficiency. J Allergy Clin Immunol 117 (2006) 870-877
38. Lin J.H., Liebhaber M., Roberts R.L., Dyer Z., and Stiehm E.R. Etarnecept treatment of cutaneous granulomas in common variable immunodeficiency. J Allergy Clin Immunol 117 (2006) 878-882
39. Notarangelo L.D., Lanzi G., Peron S., and Durandy A. Defects of class-switch recombination. J Allergy Clin Immmunol 117 (2006) 855-864
40. Ochs H.D., and Thrasher A.J. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 117 (2006) 725-738
41. Orange J.S., Hossny E.M., Weiler C.R., Ballow M., Berger M., Bonilla F.A., et al. Use of intravenous immunoglobulin in human disease: A review of evidence by member of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 117 (2006) S525-S553
42. Lavi R.F., Kamchaisatian W., Sleasman J.W., Martin D.P., Haraguchi S., Day N.K., et al. Thymic output markers indicate immune dysfunction in DiGeorge syndrome. J Allergy Clin Immunol 118 (2006) 1184-1186
43. Roifman C.M., Gu Y., and Cohen A. Mutations in the RNA component of mitochondria RNAse processing might cause Omenn's syndrome. J Allergy Clin Immunol 117 (2006) 897-903
44. Cac N.N., and Ballas Z.K. Recalcitrant warts, associated with natural killer dysfunction, treated with systemic IFN-a. J Allergy Clin Immunol 118 (2006) 526-528
45. Beeler A., Engler O., Gerber B.O., and Pichler W.J. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J Allergy Clin Immunol 117 (2006) 455-462
46. Wu Y., Sanderson J.P., Farrell J., Drummond N.S., Hanson A., Bowkett E., et al. Activation of T cells by carbamazepine and carbamazepine metabolites. J Allergy Clin Immunol 118 (2006) 233-241
47. Rodriguez-Pena R., Lopez S., Mayorga C., Antunez C., Fernandez T.D., Torres M.J., et al. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to b-lactams. J Allergy Clin Immunol 118 (2006) 949-956
48. Blanch A., Roche O., Urrutia I., Gamboa P., Fontan G., and Lopez-Trascasa M. First case of homozygous C1 inhibitor deficiency. J Allergy Clin Immunol 118 (2006) 1330-1335
49. Frank M.M., and Atkinson A. Homozygous C1 inhibitor deficiency: the conclusion of a long search. J Allergy Clin Immunol 118 (2006) 1327-1329
50. Levi M., Choi G., Picavet C., and Hack E. Self-administration of C1-inhibitor concentrate in patients with hereditary angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol 117 (2006) 870-877
51. Caballero T., and Lopez-Serrano C. Anaphylactic reaction and antibodies to DX-88 (kalikrein inhibitor) in a patient with hereditary angioedema. J Allergy Clin Immunol 117 (2006) 476
52. Feeney M.E., Tang Y., Rathod A., Knout C., and McIntosh K. Absence of detectable viremia in a perinatally HIV-1-infected teenager after discontinuation of antiretroviral therapy. J Allergy Clin Immunol 118 (2006) 324-330
53. Saitoh A., Singh K.K., Sandall S., Powell C.A., Fenton T., Fletcher C.V., et al. Association of CD4+ T-lymphocyte counts and new thymic emigrants in HIV-infected children during successful highly active antiretroviral therapy. J Allergy Clin Immunol 117 (2006) 909-915
54. Shearer W.T., Deville J.G., Samson P.M., Moye J.H., Fletcher C.V., Church J.A., et al. Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140). J Allergy Clin Immunol 118 (2006) 518-521
55. Williamson M.P., McCormick T.G., Nance C.L., and Shearer W.T. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy. J Allergy Clin Immunol 118 (2006) 1369-1374
56. Parrino J., and Graham B.S. Smallpox vaccines: past, present, and future. J Allergy Clin Immunol 118 (2006) 1320-1326
57. Glezen W.P. Asthma, influenza and vaccination. J Allergy Clin Immunol 118 (2006) 1199-1206
58. Kancherla V.S., and Hanson C.I. Mumps resurgence in the United States. J Allergy Clin Immunol 118 (2006) 938-941
59. Cardona I.D., Goleva E., Ou L.S., and Leung D.Y.M. Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes. J Allergy Clin Immunol 117 (2006) 688-695
60. Mandron M., Aries M.F., Brehm R.D., Tranter H.S., Acharya R., Charveron M., et al. Human dendritic cells conditioned with Staphylococcus aureus enterotoxin B promote TH2 polarization. J Allergy Clin Immunol 17 (2006) 1141-1147
61. Hartl D., Griese M., Kappler M., Zissel G., Reinhardt D., Rebhan C., et al. Pulmonary TH2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J Allergy Clin Immunol 117 (2006) 204-211
62. Saadane A., Soltys J., and Berger M. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kB activation, cytokine secretion and persistent lung inflammation. J Allergy Clin Immunol 117 (2006) 1163-1169
63. Antas P.R.Z., Ding L., Heckman J., Reeves-Hammock L., Shintani A.K., Schiffer J., et al. Decreased CD4+ lymphocytes and innate immune responses in adults with previous extrapulmonary tuberculosis. J Allergy Clin Immunol 117 (2006) 916-923
64. Fuller C.L., Brittingham K.C., Hepburn M.J., Martin J.W., Pettit P.L., Pittman P.R., et al. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination. J Allergy Clin Immunol 117 (2006) 1186-1188
65. Mitre E., and Nutman T.B. IgE memory: persistence of antigen-specific IgE responses years after treatment of human filarial infections. J Allergy Clin Immunol 117 (2006) 930-945